FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Can Vet J / Owners’ perception of the efficacy of Newmarket bloodr...
The Canadian veterinary journal = La revue veterinaire canadienne2014; 55(7); 683-686;

Owners’ perception of the efficacy of Newmarket bloodroot ointment in treating equine sarcoids.

Abstract: A retrospective questionnaire-based survey was used to determine the perceived efficacy of Newmarket bloodroot ointment in treating equine sarcoids. In 49 horses with 74 sarcoids, 64 sarcoids responded either completely (n = 49) or partially (n = 15) while 10 did not respond or worsened. Sarcoids < 2 cm responded better to treatment (P < 0.001) than did larger sarcoids. Un sondage rétrospectif réalisé par questionnaire a été utilisé pour déterminer l’efficacité perçue de l’onguent à la sanguinaire de Newmarket pour traiter les sarcoïdes équines. Chez 49 chevaux atteints de 74 sarcoïdes, 64 sarcoïdes ont soit répondu complètement ( = 49) ou partiellement ( = 15) tandis que 10 n’ont pas répondu ou se sont aggravées. Les sarcoïdes de < 2 cm ont mieux répondu au traitement ( < 0,001) que les sarcoïdes plus grandes.(Traduit par Isabelle Vallières).
Get Full Text
Publication Date: 2014-07-02 PubMed ID: 24982522PubMed Central: PMC4060914
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the effectiveness of a specific ointment (Newmarket bloodroot ointment) in treating equine sarcoids, a common type of horse skin tumor. The study used a survey to collect data and found that the ointment was effective for treating small sarcoids, but less effective for larger ones.

1. Methodology

  • The researchers used a retrospective questionnaire-based survey method for this study. This means that they collected data based on people’s recall of past events, in this case, the effects of using the Newmarket bloodroot ointment on equine sarcoids.
  • 49 horses with a total of 74 sarcoids were included in the survey.

2. Results

  • Out of the 74 total sarcoids, 64 responded positively to the treatment. The researchers categorized the responses into two types: complete response (49 sarcoids) and partial response (15 sarcoids).
  • A complete response meant that the sarcoid was entirely eliminated while a partial response referred to the sarcoid shrinking in size but not disappearing entirely.
  • The remaining 10 sarcoids did not respond to the treatment or even worsened after the application of the ointment.

3. Impact of Sarcoid Size

  • Interestingly, the size of the sarcoids affected how well they responded to the treatment. Sarcoids that were smaller than 2 cm in diameter responded better to the Newmarket bloodroot ointment.
  • This was a statistically significant finding with a P-value less than 0.001, which means that there is less than a 0.1% chance that this result is a coincidence.
  • This suggests that the Newmarket bloodroot ointment is particularly effective for treating smaller equine sarcoids, but may not be as effective for larger ones.

4. Conclusion

  • This study indicated that Newmarket bloodroot ointment could be a beneficial treatment for equine sarcoids, particularly those smaller than 2 cm. However, the effectiveness may decrease with larger sarcoids.
  • It may prompt for further investigation to improve the ointment’s effectiveness on larger sarcoids or develop alternative treatments for these cases.

Cite This Article

APA
Wilford S, Woodward E, Dunkel B. (2014). Owners’ perception of the efficacy of Newmarket bloodroot ointment in treating equine sarcoids. Can Vet J, 55(7), 683-686.

Publication

The Canadian veterinary journal = La revue veterinaire canadienne
ISSN: 0008-5286
NlmUniqueID: 0004653
Country: Canada
Language: English
Volume: 55
Issue: 7
Pages: 683-686

Researcher Affiliations

Wilford, Sophie
  • Department of Clinical Science and Services, Equine Referral Hospital (Wilford, Dunkel), and Final Year Veterinary Student (Woodward), The Royal Veterinary College, North Mymms, Herts AL9 7TA, United Kingdom.
Woodward, Ella
  • Department of Clinical Science and Services, Equine Referral Hospital (Wilford, Dunkel), and Final Year Veterinary Student (Woodward), The Royal Veterinary College, North Mymms, Herts AL9 7TA, United Kingdom.
Dunkel, Bettina
  • Department of Clinical Science and Services, Equine Referral Hospital (Wilford, Dunkel), and Final Year Veterinary Student (Woodward), The Royal Veterinary College, North Mymms, Herts AL9 7TA, United Kingdom.

MeSH Terms

  • Animals
  • Female
  • Horse Diseases / drug therapy
  • Horses
  • Humans
  • Male
  • Neoplasm Recurrence, Local
  • Ointments / chemistry
  • Plant Extracts / administration & dosage
  • Plant Extracts / adverse effects
  • Plant Extracts / chemistry
  • Plant Extracts / therapeutic use
  • Sanguinaria / chemistry
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / veterinary
  • Surveys and Questionnaires

References

This article includes 20 references
  1. Taylor S, Haldorson G. A review of equine sarcoid.. Equine Vet Educ 2012;25:210–216.
  2. Knottenbelt DC. A suggested clinical classification for the equine sarcoid.. Clin Tech in Equine Prac 2005;4:278–295.
  3. Marti E, Lazary S, Antczak DF, Gerber H. Report of the first international workshop on equine sarcoid.. Equine Vet J 1993 Sep;25(5):397-407.
    pubmed: 8223371doi: 10.1111/j.2042-3306.1993.tb02981.xgoogle scholar: lookup
  4. Bogaert L, Martens A, Depoorter P. Equine sarcoids, part 2: Current treatment modalities.. Vlaams Diergeneeskd Tijdschr 2008;78:62–67.
  5. Christen-Clottu O, Klocke P, Burger D, Straub R, Gerber V. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus).. J Vet Intern Med 2010 Nov-Dec;24(6):1483-9.
    pubmed: 21039860doi: 10.1111/j.1939-1676.2010.0597.xgoogle scholar: lookup
  6. Predny M, Chamberlain J. Bloodroot (Sanguinaria canadensis): An annotated bibliography, US Department of Agriculture, Forest Service, Southern Research Station.. 2005. [Last accessed May 6, 2014]. pp. 1–55.
  7. Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells.. Clin Cancer Res 2000 Apr;6(4):1524-8.
    pubmed: 10778985
  8. De Stefano I, Raspaglio G, Zannoni GF, Travaglia D, Prisco MG, Mosca M, Ferlini C, Scambia G, Gallo D. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.. Biochem Pharmacol 2009 Dec 1;78(11):1374-81.
    pubmed: 19643088doi: 10.1016/j.bcp.2009.07.011google scholar: lookup
  9. Park H, Bergeron E, Senta H, Guillemette K, Beauvais S, Blouin R, Sirois J, Faucheux N. Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways.. Biochem Biophys Res Commun 2010 Aug 27;399(3):446-51.
    pubmed: 20678472doi: 10.1016/j.bbrc.2010.07.114google scholar: lookup
  10. Sun M, Lou W, Chun JY, Cho DS, Nadiminty N, Evans CP, Chen J, Yue J, Zhou Q, Gao AC. Sanguinarine suppresses prostate tumor growth and inhibits survivin expression.. Genes Cancer 2010 Mar;1(3):283-92.
    pmc: PMC3036540pubmed: 21318089doi: 10.1177/1947601910368849google scholar: lookup
  11. Pica F, Balestrieri E, Serafino A, Sorrentino R, Gaziano R, Moroni G, Moroni N, Palmieri G, Mattei M, Garaci E, Sinibaldi-Vallebona P. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer.. Anticancer Drugs 2012 Jan;23(1):32-42.
    pubmed: 21849887doi: 10.1097/cad.0b013e32834a0c8egoogle scholar: lookup
  12. Foy JM, Rashmir-Raven AM, Brashier MK. Common equine skin tumors.. Compend Contin Educ Vet 2002;24:242–252.
  13. Pettersson C. Utvärtes behandling av sarkoider på häst med Aldara™ eller Xxterra™-en jämförande pilotstudie. [MSc Dissertation] Uppsala, Sweden: Sveriges lantbruksuniversitet; 2008.
  14. Nogueira SA, Torres SM, Malone ED, Diaz SF, Jessen C, Gilbert S. Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study.. Vet Dermatol 2006 Aug;17(4):259-65.
    pubmed: 16827669doi: 10.1111/j.1365-3164.2006.00526.xgoogle scholar: lookup
  15. Stadler S, Kainzbauer C, Haralambus R, Brehm W, Hainisch E, Brandt S. Successful treatment of equine sarcoids by topical aciclovir application.. Vet Rec 2011 Feb 19;168(7):187.
    pubmed: 21493530doi: 10.1136/vr.c5430google scholar: lookup
  16. Knottenbelt DC, Edwards S, Daniel E. Diagnosis and treatment of the equine sarcoid.. In Pract 1995;17:123–129.
  17. Carr EA, Théon AP, Madewell BR, Griffey SM, Hitchcock ME. Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States.. Am J Vet Res 2001 May;62(5):741-4.
    pubmed: 11341396doi: 10.2460/ajvr.2001.62.741google scholar: lookup
  18. Carr EA, Théon AP, Madewell BR, Hitchcock ME, Schlegel R, Schiller JT. Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses.. Am J Vet Res 2001 Aug;62(8):1212-7.
    pubmed: 11497440doi: 10.2460/ajvr.2001.62.1212google scholar: lookup
  19. Bogaert L, Martens A, De Baere C, Gasthuys F. Detection of bovine papillomavirus DNA on the normal skin and in the habitual surroundings of horses with and without equine sarcoids.. Res Vet Sci 2005 Dec;79(3):253-8.
    pubmed: 16054896doi: 10.1016/j.rvsc.2004.12.003google scholar: lookup
  20. Knottenbelt DC, Walker J. Topical treatment of the equine sarcoid.. Equine Vet Edu 1994;6:72–75.

Citations

This article has been cited 2 times.
  1. Weber LA, Funtan A, Paschke R, Delarocque J, Kalbitz J, Meißner J, Feige K, Kietzmann M, Cavalleri JV. In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.. PLoS One 2020;15(11):e0241448.
    doi: 10.1371/journal.pone.0241448pubmed: 33151949google scholar: lookup
  2. Croaker A, King GJ, Pyne JH, Anoopkumar-Dukie S, Liu L. Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses.. Int J Mol Sci 2016 Aug 27;17(9).
    doi: 10.3390/ijms17091414pubmed: 27618894google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.